Detalhe da pesquisa
1.
Role of a 48-week pegylated interferon therapy in hepatitis B e antigen positive HIV-co-infected patients on cART including tenofovir: EMVIPEG study.
J Hepatol
; 61(4): 761-9, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24882048